Imprivata
PrivateLast Round
Corporate Funding
Apr 11, 2022
Est. Valuation
$3.5B
Total Funding Raised
$72M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Imprivata is a cybersecurity company that provides a digital identity platform for mission- and life-critical industries, with a primary focus on healthcare.
Sector
Cybersecurity
Verticals
Identity & Access, EHR & EMR, Zero Trust, Compliance & Risk
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imprivata Comparables
Compare Imprivata with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ping Identity | 82% | |
| Okta | 78% | |
| Saviynt | 74% | |
Imprivata Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 11, 2022 | ||||
| Buyout/LBO | Sep 16, 2016 | ||||
| IPO | Jun 30, 2014 | ||||
| Series C | Apr 7, 2008 | ||||
| Series B | Jan 18, 2006 | ||||
Series A | Apr 1, 2005 |
Key People
Founding team and executive leadership
Imprivata Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cove Hill Partners | Corporate Funding |
| Stephens | IPO |
| Highland Capital Partners | Series C, Series B, Series A |
| General Catalyst | Series C, Series B, Series A |
| Sapphire Ventures | Series C |
| William Blair & Company | IPO |
| Wells Fargo Securities | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased to 263, representing 21% of headcount.
- Apr 1, 2026
North American healthcare market drives over 70% of revenue.
Imprivata Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imprivata's valuation, stock price, and market status.